Aveanna Healthcare Holdings Inc. (AVAH) Earnings Call Transcript & Summary
September 16, 2026
Earnings Call Speaker Segments
Pito Chickering
analystAll right. Thank you for joining us. Sorry for running a few minutes late. Very pleased to have CEO and CFO from Aveanna Healthcare. For anyone that doesn't know about this company, I just want to point out this thing is up 1,700% since you took ownership in end of 2022, start off as a stressed equity, almost not making payroll. Here we are, 14x leverage huge into arguably too low. This big move 1700% that's not so bad. This move has been basically been primarily moving into preferred networks, which is structurally involved sort of your entire company. So I guess, can you just talk about the preferred network strategy in each of the segments? And where are we in terms of inning feed segments as you think about this over a 1-, 2-, 3-, 5-year window? And when it gets sort of fully penetrated and start growing typically at more "market growth?"
Jeffrey Shaner
executiveSounds great. And I want to take the complement because you were 1 of the people who pointed out how bad we stuck on the way down from $10 back to one. So I just want to say thank you, Pito, for giving us some kudos on the other side of it, as you certainly brought up some of the realities to us back in 2021, 2022. But now as you said, Peter, we've been on a multiyear journey. Matt and I and Debbie Stewart, our Chief Panofficer, all kind of took our roles and early 2023 coming out of COVID, we absolutely needed a strategy that dealt with the lack of caregiver capacity in our businesses, obviously, with the hyper wages that all happened through the COVID period. We're in year 4 now of our preferred payer strategy, government affair strategy, both are continuing to work incredibly well. As you talked about in each 1 of our businesses, we underpin our growth and where our clinicians, our focus every day is to know where every 1 of our clinicians is going why they're going there, not just the patients they're seeing, but who is the payer of the patients they're seeing -- and it is that payer in our preferred network and it's sort of the allocation of our clinical capacity. So start with our largest division, our Private Duty Services division, 80% of our revenue is in privacy services. it's our most mature preferred payer market or segment. At the end of Q2, we had 37 preferred pay arrangements roughly 64% of our total volumes are in 1 of those arrangements, sets up from 57% at the begin of the year. So nice movement year-to-date. And really preferred payer. Wins in 2026 today and a couple more that we plan to announce in the second half of the year. So we're going to go right now if you want to -- this is being webcast -- this is really lots were sorry for live here. I'll give out the winning lottery to take it here in a few minutes. But really it's going to end up being a great year for PDS. I'm sure we're going to get to California, we're going to talk about some of the government affairs wins as well. But really continued to be a great momentum with our PDS preferred payers, they want more. Even our very first preferred payers still with us today. the CEO was here this morning. You guys were talking to her. So they've been a great preferred payer for us. They're still with us. They still want more capacity from us. So our very first preferred payer we're about 55% of their census in the specific state. We signed up first contract 4 years ago, and they still want us to take more. They want more nurses, they want more of our capacity because it truly has been in the total cost of care for them. So excited about where PDS goes, put able quickly to home health and hospice. Also really excited about where our home health and hospice teams are 50 preferred payer agreements, Think of those as episodic agreements, both Medicare and Medicare Vantage but all episodic in nature 81% of our business is aligned with an episodic contract in home health that is we believe it's industry-leading, certainly to the higher end of the industry, and we're growing 15.5% year-over-year organically in the home health business. Really, really proud of that. Lastly but not least, we've just finished the Medical Solutions modernization in 2025, coming in early '26. And we've got our first 20 preferred payers identified. We're really working that preferred payer process and the med solutions. It's still stage, but proud to be bringing the preferred payer strategy to Med Solutions as well.
Pito Chickering
analystYes. So 1 of my biggest. Pushbacks in the last couple of years has been your conservatism, which is he should be whipped over there and to Avion's board outside they look at Bloomberg surprise. In terms of seat numbers versus active members in Europe beating by 80% or 50%, it's maybe you're guiding the Street to be too low. I guess if I think about growth in '26 and growth in '27 sort of put out sort of long-term growth rates here. I guess the thing about like this. How much percent of those long-term growth rates are coming from just overall market growth how much are coming from sort of market share for preferred networks? And how much is that coming from just simplistically the sort of very sick kids. There are stuck in hospitals that don't have actually a way of getting home.
Jeffrey Shaner
executiveLet me start with why we kind of got to the long term and jump in with the actual growth rates by segment. But you were kind enough at the end of Q1, just to remind us how much we beat consensus by and that was too much from your professional experience. So -- we spent effectively May through the end of July with our Board looking at reunderpinning all of our business units. And really, the key drivers was we were 15 or 16 months into the One Big Beautiful Bill, and we had enough experience now with 32 states, 32 Medicaid states. And with the rate wins from 25, we knew what the rate wins for 26 were shaping up to be we had just gone to California news that we had gotten in the California budget for 2027. That was a big deal for us, 32nd state. And then we hired Capstone to underwrite all 50 states, the impact of BBA. And specifically, what was in their best systemization, what would the output be to the pediatric private duty nursing population. We had strong feelings because we're in it every day, but we really needed a market validation. And all of that kind of came together in the summer with -- the 1 big beautiful bill is real, and it does impact Medicaid. We know that. It does not primarily target pediatric PDM. And if anything, our pediatric PDM population is incredibly well insulated. States are going to continue to invest generally into pediatric PDM care because it's a winning solution for them. The other thing that was helpful was we had -- we're big betters on home health, get home health and we saw in the 25 final rule, what we thought was a turn in the policy of this administration. When we saw the proposal, we'll come out in July, it validated. We think home health has turned. We think the trough has happened, and we're starting the way back up in home health. That was a nice validation for us to reunderwrite the growth algorithm. As Matt will talk about really give us confidence. And probably the best way I could give you is clarity. We felt like we had enough clarity at this point to readdress our long-term growth algorithm. .
Matt Buckhalter
executiveYes. And Pito, I think there was a compliment in there somewhere with 14 consecutive quarters of beating raising guidance. But by huge amounts maybe stats. -- average of 40% to 50%, it's been process. We've done a pretty nice job as an organization. But to kind of echo Jeff here a little bit with our long LRP updates that we had, there was a lot of noise that came out with the BBA, and there was quite a bit of noise of just what is this going to mean to us? Is there going to be friendly fire? Are we going to get elected by this? Is it just going to be across the board cuts to happen in Medicaid? And what we have felt since then is absolutely nothing. We have had no interruption to our authorizations, no interruptions to our started care, no interruptions to our payment cycles. Everything has just been business as usual in the best possible way out there. And so as we were even a little bit more conservative at the beginning of the year, just as we wanted to see things, how they settled with the and year-to-date, 7-state rate wins right on plan with our expectations even additional preferred payers, getting that to 64% of our MCO volumes on preferred payer contracts themselves. All that's just been more underpinning of just, hey, guys, this is the lowest cost setting that anybody can be in who are going to continue in the PDS services, and they're not impacted by the OBBA. And so taking our PDS growth range, LPs from 3.5 -- 3% to 5% from 5% to 6%. And as well as updating our home health and hospice from that 5% to 7% to the 8%, 10%, even on that one, looking at a positive rate environment for the first time in 6 years. Now that's kind of -- it was nice to see a proposed rule come out and not half panties around it for the first time in 5 years. And so we're seeing that be 2.4%, 2.5%. That's our expectation going forward as well. So that gave us confidence to move that up another 2 percentage on our growth rate. And then even on the Medical Solutions side, we kept that at that 8% to 10% range. Last quarter, we were right around 9%. We expect that to get back to a single digits or high single digits, low double digits here in the next quarter or 2, just as we finish off that modernization effort and put our repair work on that division as well. So a lot of great work that the teams have done thoughtfully over the last few years. You can't do it all at once, focus on one, focus on, focus on 1 we've been able to accomplish a lot and get the company to where it is right now.
Jeffrey Shaner
executiveI know we'll get into M&A later, but also all of the execution in the last 3.5 years has led to -- you've mentioned it, but a significantly improved capital structure. -- massive deleveraging the balance sheet, producing nice free cash flow. So the other thing that we updated in the LRP was really the M&A update of we were effectively in the and we updated that 2% to 4%. We've been above that the last 2 years with Thrive and Family First. My assumption is we'll play on the higher end of that scale, if not above that in the next few years, but we were able to also put an improved capital structure, lean back into M&A in a more material way.
Pito Chickering
analystLook if I have to write to get earnings now 3Q of 27. So a year from now, and you guys have another big basically, it's a different way of asking the kind of where could these levels be conservatism? Would it be you keep on driving new preferred contracts that you're driving depth within these contracts. Is it because of more states of California to reprice their offerings? Or is it just from the SG&A leverage, I don't think you're guiding to a whole lot of margin expansion despite SG&A come down 140 basis points a year for the last couple of years.
Matt Buckhalter
executiveYes. I would tell you it's growth. I mean growth is going to be the main driver of that one. And we've done a great job. And Mattel getting to California here in a little bit. But California was the last state to kind of move 32 to 32. And we can now just compete in every single state that we're in Pito. Like there was the black sheet over there that we just couldn't do anything with. We're going to hire caregivers, we can provide clinical outcomes. Families or upside, kids are stuff in the hospital. With the 1 on go live of that one, that will help California. And now in every single state in 39 states, 32 in the PDS division, we can compete. It's never easy. It's never going to be easy. Caregivers are in high demand. There's a lack of caregivers out there. It's also the reason why the preferred payer strategy also works in there. But I think if you -- if there is a beat that comes out there, it will continue to be on the volume side of things, less on the rate side, just because there continues to be that pent-up demand for our services. .
Jeffrey Shaner
executiveI would also say just more of the same. So a year from now, with the exception of a little bit more meaningful M&A, I would tell you more of the same, that we're going to continue doing the things that have been incredibly successful for the last 3.5 years. Being very effective and efficient in the back office, to your point, getting SG&A leverage or maybe some of our AI and automation from the back office in collections to the front-facing and scheduling and some other dictation type exercises that are actually in the branch in the homes, better bring some efficiencies to us in the future out years in the branches, but continuing to drive the preferred payer strategy. I agree with Matt. We've solved the 32 states. We'll be back to the table with 8 or 10 additional states next year, looking for colo level adjustments, meaning anywhere from 2% to I'd call it, 10%. And we have about 1/3 of our states every year that we're winning rate, but I think at this point that those are going to be smaller rate enhancements, and we're okay with that. That works in our growth algorithm. And I just think doubling down on home health. I mean we are living so far above what the industry is living today from a growth standpoint, a margin clinical outcomes, we need to double down in that business with our team.
Pito Chickering
analystOkay. So California, obviously, pretty big shift there. And frankly, I'm a little amazed that it came through in the economic savings this data is so high. You guys have talked about sort of $10 million. We modeled sort of like low 20s. As you think about like the timing of sort of how California comes in, the size of California. And then also I think you talked about sort of giving rates ahead of time and I think about 4Q '26 versus 4Q '27?
Jeffrey Shaner
executiveLet me start with just the work that was done and the Matt will talk about the wage pass-through side of it. But to your point, we're 5 years into advocating and lobbying for this freight increase. We've had a 40% -- there's 1 PDN rate in the entire state, which is simplistic, it doesn't necessarily make sense for the wage metrics of other state. But one PDN rate of $44.12, we have asked for 40% -- we the industry has been asking for a 40% PDN rate increase now for almost 5 years. I think part of the story is just how do you stay at the table, you keep talking, you keep advocating. We don't leave states when we don't get rate increases, right? We stay at the table, we fight for our families -- and so I think there's a story here of like just staying at it being committed to the outcome to these families. And ultimately, the last 4.5 years, our California business was just slowly dying on a line with no rate lift, very, very few MCO opportunities in the state. Most of our children are still on the Medical program. The business went from relevant 5 years ago, last rate increase was 8.5 years ago, to irrelevant or irrelevant for our business model in '25 and '26. So as a company has been accelerating and growing California is slowly going behind the scenes. Clearly, that's about the change in a material way. So we're excited to be able to put California back on the map, be relevant. We're one of the two largest providers in the state. We cover the entire state, which is great. So the infrastructure there to be able to go execute. Matt will tell us more about our Q4 plans and how we grow in 2027. .
Matt Buckhalter
executiveYes. Really excited for our patients and our families, most importantly. I mean it's been 8 years -- 8.5 years since our last rate increase there. And in that time period, COVID happen, hyperinflation, nurse caregiver inflation. It's been a tough, tough environment for the last 5 years out there. In Q4, we're actually going to front run this wage pass-through a little bit. And so we're going to invest a couple of million dollars in to continue the ramp-up period. And I was going to think about it in 3 stages, Pito. The first stage is our current caregivers who are working for us at this time and maybe were their second job because they had to go work a different position that was paying more in the Sicilian facility or a skilled nursing facility. But when we're able to move their wages, books now or $7 an hour they're going to want to pick up more shifts for us. And that will focus on our patients themselves and getting their fill rates up from their authorized owners. Next step is going to be the caregivers who used to work for us. They love home care. They love the one-on-one patient experience. They love the patients, the families, they love also being 2.5 miles down the road from them instead of driving 25 miles into the city to provide care. Those are going to be the next ones that we pull over. They're already up on compliance. They probably have open shifts on the families that they previously worked. And they also once again love that home care. We can get them reengaged relatively quickly. Those are probably our two first big jumps that happen on a volume standpoint itself.
Jeffrey Shaner
executiveAnd we'll do that with our cash flow our expense our risk. It's the right thing to do. investment. And think of -- I think we've talked publicly, think of. What should be between 80% and 85% ideal fill rate in California is somewhere closer to 50% or sub 50% over the last 4 years. And to Matt's point, our goal is to reconnect that with the first 2 groups that you just talked about. Over the next 3 to 6 months. As soon as the rate table is published by the department -- the Medical department, we'll start that pass-through with the intention to start to reconnect quickly 50%, 55% to 60% eventually back to 80%, 85%, all -- and that said, all with our current patients.
Matt Buckhalter
executiveYes. And the next step will be just new hires, new patients. So obviously, the McPick us are full California. There's more 10 children hospital in the state itself. So how do we get those beds and how do we get those patients home that have been sitting there for 6 months post the charge date, 8 months post discharge date who just don't have nursing care. And that's the reason the state made the investment because those are the or dollars that they can recognize very quickly and the hard savings they can recognize very quickly. We also don't want to take until we take care of our current patient base that I've stuck with us the entire time, too. So there will be new caregivers, new hires, new start of care, new emissions. That will take time. So that 1 -- so the first one will be quicker. The next one will be pretty quick. The next one will take 12, 18, 24 months before you kind of see that actual impact of what this rate is for us. And it's a little bit of the upfront investment that California has to make to get to the savings they desire as well.
Jeffrey Shaner
executiveWe saw this in Georgia 3 years ago. There's 1 children's hospital in Georgia, so it was easier but it took about 120 days to pull 50 or so families out of the hospital and get them home for good. California will be that times 10. So I agree, Matt, this is going to take us and our peers probably close to a year to fully bake in getting in an efficient stream of patients out of the hospital. If you think about 2 to 4 nurses for every patient we take home from the hospital, you think about how many patients you had to hire to basically chronic children and out of 10 children's hospitals in the state of California. So it's a great growth algorithm for '27, but it's also a growth algorithm all the way through '28.
Pito Chickering
analystI mean does the tool rating you talked about were all those potential house in California. And there are other hospitals which they're being capitalized as to hospitals. And obviously, the rate increases for 5 years, -- can you quantify the number of in California of kids obviously uses for asset government for money because you're going to quantify how many kids are currently in California stuck as I think about your other states that you exist in, how big is that number? And nothing about the states you aren't in today to how big as a number. And this is not about like market share is just about how many kids sort of in those 3 buckets of our sales stocking hospitals. Think about your highest acuity patient. .
Jeffrey Shaner
executiveIn no way, there's no perfect answer because there's no perfect report, but the best we can tell in California, this is inmate shared with the governor's office and the Head of the Department of Health and Home Services over the last 4 years is 4,000 -- roughly 4,000 children in California should be receiving at home, privately nursing daily in California, they only qualify if they have event or track or both. So it's a pretty high level compared to most of those states. The best we can tell the number of kids being serviced is somewhere below 3,000. It's hard to tell at this point. But somewhere sub-3,000 and factor Aveanna and 1 of our national peers are the 2 largest provider-only providers that cover the entire state. So think of the opportunity being somewhere around 1,000 or 1,400 kids who just -- who either parents are providing the care daily or are stuck in a hospital somewhere or we have been in some kind of long-term institutional care waiting to get home. Now that's a lot of children that would take us normally 5, 6, 7, 8 years to admit that many. Thankfully, we have peers in the market, but it just shows you the unlock in California is that significant. The idea for us to take a couple of hundred of new patients home in the state is a big deal in the course of the year. So I think we see the growth algorithm in California being a 2- to 3-year growth. Eventually, the new rate will run its course over probably a 3-year period. But for the next year to 2 years, we see a clear path to being able to eat into that unlock. And Matt said it, but I will go back to if you're a parent of a child who's got to be seen 24s a day and you only have like 50 hours of nursing care a week, that's 1 time you can sleep. It's the only time you can actually eat or go out of the house. So the idea that you could get -- and your authorization might be up to 24 hours a day, 7 days a week or 168 hours a week. The idea that you get nursing up to that and be a human being gain is so monumental for these families. So I say that to say, it's a huge deal for the families in California. It's a big deal for Aveanna. As you know, we've been talking about it for I was just done talking to you about. I mean, at some point, I was just -- I was hiding from you about California. So like you, I'm glad to have it now be fact and we'll be more excited as we get into 2017, where it's in print, and we're actually out executing. Outside of that, we've talked about 7 states that we're not in that we want to be in, in Medicaid. Think of -- I'm not picking on the big 10 here, but think of Michigan, Ohio, West Virginia, Kentucky, Tennessee, Missouri, Arkansas, kind of the 7 states we're not in PDS that we feel like we need to round out our large peers -- payer peers are asking us to go to some of states specifically Tennessee and Ohio. So that's a nice fill-in for us. These are large Medicaid systems, large mature Medicaid systems, not the highest PDN rates, but good mature Medicaid system. So .
Matt Buckhalter
executiveMedicaid systems, good population to say they have labor force you can actually hire as well. And I think I echo 1 thing you said, Jeff. -- our preferred payers are asking us to be there. They're asking us to go to Tennessee. They're asking us to go to Ohio. They've got problems. And so that's an area that we want to focus on getting there sooner than later.
Jeffrey Shaner
executiveAnd to your point, all new geography, all new preferred payer opportunities. And for us, a diversification of a Medicaid portfolio makes a ton of sense. We've seen it with the 32 states, we really benefited from being in that -- and taking -- sorry, 32 closer to 40 long term to us make some time sense. .
Pito Chickering
analystSo I mean, so I guess the same color question as I think about Tennessee and Ohio, what percent of those orders are getting filled just not by you guys...
Jeffrey Shaner
executiveMuch more robust. I mean I would tell you to the best of our knowledge in those 7 states, 6 of the 7 or 77 have appropriate rate structures where the rate is not broken. So it's not a California like. For us, to Matt's point, is the payers saying we want you to go there and we have a preferred rate already in place for you, and we want you to help take -- sell some of our problems. Ohio -- Michigan and Ohio are probably the 2 biggest Medicaid states in those 7 states. We listed those are very, very large Medicaid states. So -- but they're just important for us as we round out our portfolio, you talked about '27. But as we think about '28, '29, '30 us being around a 40 state, 40, 41 state Medicaid provider is probably the ideal. I know you'd like us to be in Montana for personal reasons and maybe Idaho like that where the fishing is good, the hunting is good but an event we'll get there.
Matt Buckhalter
executiveBut right now, we're going to some more focus where our partners are asking us to really.
Jeffrey Shaner
executiveStill in the core states and then we can.
Pito Chickering
analystSo Matt, just to bring you on to this, we've seen AR reserve tailwinds for the last 2 consecutive years. Can you keep this going? Like is this -- like how much more is there as do here? And then more in all seriousness, there's been a lot of in besides rates and preferred networks and EBITDA growth with the cash flows and a lot of these things happening like crack it down reserves kind of can you sort of talk about the other benefits that you've seen in terms of this new operational structure over the last couple of years.
Matt Buckhalter
executiveThat's exactly what it's been to. And this is surprise we didn't necessarily expect when we rolled out the preferred payer agreements per payer contracts. They cause us to meet with our preferred payers, monthly, quarterly and you're sitting across the table with them at any given time. And those conversations, you're working on hospitalization rates. You're talking about HBR scores and your cohort of patient base and where we're currently sitting at. And you're asking them, "Hey, what problems do you have?" And like "Hey, these patients are really difficult for us. There's been rehospitalization 3 times. Can you lean into this one." And in that conversation, they also return the favor and say, what issues are you having? Like, "Well, I get this AR that's locked up from 2023. It's fully reserved. It's gone through a waterfall process. It's all accounted for. but he missed XYZ paperwork. Can we get that taking care of that Yes. Sure. Of course, you provided the care, you did what you asked, like, yes, no problem. That never happened prior to this one, probably because we didn't have somebody to call were calling a 1-800 number or hotline to try to get something out yet. No, thanks. And it was really the relationships that we've built out there with the preferred payer network. That we're getting payer faster. We're resolving issues quicker. And it's just working together as a partner is really the easiest, simplest way to put it. To your point, we've had some tailwinds here with some of that aged AR pickups out there. Those won't last. We've picked up $5 million here or $6 million there. But our reserve rates have never been lower in all 3 of our divisions, and I'll be on a history and the history of it. So between all 3 of them, are reserves that we're actually booking is the lowest it has ever been. A lot of that is through some automation we put into place. We've acquired 2 companies over the last 2 years. We added 0 to our RCM. We've been able to not backfill positions as we've had some turnover occur. And we put some automation in some AI technology in there that's really helped us just leverage that piece and you alluded to our SG&A leverage, leverage our entire SG&A platform as well. We're going to start pulling that across in 2027 to more being forward facing, but we've done a really nice job on the SG&A front with it, too.
Jeffrey Shaner
executiveAs a good CFO, he's told me every quarter. There's no more reserve left right .
Pito Chickering
analystHe's telling me to see anything whenever I push them on the post earnings calls and the point I just don't buy it anymore. I will validate Prices are good .
Jeffrey Shaner
executiveIt is such a nice partnership when your payer partner wants to help you solve a claims issue. Many times, it's just the adjudication of claims that is tough. And Matt said, the fact that our payer partners are wanting to help us solve these issues. It goes against everything that people hear just anecdotal, but sometimes you buy what you do, I say I'm in the health care. United Healthcare. I'm like, yes, I know you they saw -- they actually don't. They're actually good human beings they actually try really hard to work with their partners and take care of their beneficiaries. I always ask people, do you have United as a coverage No, I don't. They just suck. I'm like, okay, we work them every day. They're actually great people, and they do a great job. And they hold you a high level of accountability as a provider. They expect high things from you, all of our preferred payers. They expect high quality from us. And -- but when you treat them as a business partner, they will treat you as a business partner, and we have found that to be, to your point, on accounts receivable collections. -- just a win-win.
Pito Chickering
analystSo if I want to put a negative hat on here, this is 1 of the big base always happens. You roll into recession states are required to also budget by law. -- which means all of a sudden, tax revenues go down and typically costs go up and therefore, the question around Medicaid rates is always there. What happens in your stage when there's Medicare fee for service or management can be to roll into recession. -- tax revenues collapsed, they're looking for savings, do they really realize enough how much your area is savings or you guys got caught up in just the mass cuts that seem to happen every recession.
Jeffrey Shaner
executiveLet's give you 2 examples of it because I think both is the answer. So many of our states are managed Medicaid now Lake Texas as an example. We don't see -- we don't here for any -- I'd say it may be less than 1% of our business is actually Medicaid reimbursed in Texas because 99% of our business is paid through the MCOs. Which means the MCOs are at risk, right? They are the capitated risk in that scenario. And I would tell you in that scenario, they absolutely understand the cost savings, and they would push us harder for even more savings. But they may not give us rate increases but they would push us harder and harder for lower the HPR percentage in our contract, save us more money. We like that. We like where the answer is BMCO is the person who's responsible for not balancing the budget, but ultimately, is the outsourced Medicaid product. Most Medicaid systems like Georgia, now like California, they understand the value proposition. So we've seen it play through in material rate increases. We have 1 example of this Colorado of a state that has a global Medicaid issue, and they've come across with a 2% temporary rate decrease, right? And we're part of that. That's been in place now it's 2 last fiscal year and this fiscal year. And in Colorado, they kind of ran off the tracks of Medicaid, unfortunately. They kind of covered everything, not just PDM, but everything under the sun and eventually just disconnected, rate reimbursement and expenses disconnected. We are actually, I had to say pleased. We understand what Colorado has to go through. We're one of the largest providers of PDN in Colorado. And we're going to be there on the other side of Colorado's fixing their Medicaid product. And so I'd use that as an example of like 32 states, well diversified. Colorado is a big state for us, and we're proud to be there. And we're fighting through a 2% temporary rate cut there. But it's 1 of 32 states that's implemented that. And when it's all said and done, our growth algorithm doesn't change because Colorado put a 2% rate decrease. We don't like it, but we will be one of the companies that survive while some of the mom-and-pops. I think some of our competitors ultimately cannot be efficient enough to make it through that.
Matt Buckhalter
executiveYes, Colorado also had 10 years in a row rate increases every single year too. So it was up in there of 20% on time as well. So they've been a great state to operate in, and we'll continue to be great state to operate in. But I think the diversity of our 39 states that we're in as the real big winner there. I'd also say to kind of totally shifting away from the reimbursement structure. If that situation that occurred, which nobody likes to whisper out loud, we are an area that the workforce can come back to. Our demand for services is always going to be there. And so an LPN and RN needs to get back on the workforce, maybe they look at a period of time, maybe the plan to go take care of their own children as they age and grew up, we are an opportunity for them to reengage into the workforce quickly and to get a paycheck very quickly as well. So there's actually a positive on the labor front for us as well because of the demand for the services, but I understand where you're getting at on the reimbursement side. we also think just being the lowest cost setting is always going to win out at the end of the day, like the moment you're at 10x saving as opposed to acute care setting, people are going to pay attention to you.
Jeffrey Shaner
executiveAnd that's where we finally got this summer with the 1 big beautiful bill was all of the noise about Minnesota, all the noise about California, both states implemented a PDN rate increase over the last 18 months, both states north of 30% PDN rate increase. They didn't do it to be to be wasteful. They didn't do it to be despite full to CMS. And by the way, CMS will have had to approve both of those rates, and they approved them in Minnesota. We know that we expect them to improve the California with no drama. So even CMS is saying, yes, this is a good place to invest in rate to save total cost of care, almost all of it, if not all of our value-based contracts in our PDN we have 15 base contracts. I think it's presale. Almost all of them are underpinned by a total cost of care. So the only way we earn a bonus is that we are lowering the total cost of care, which I think is a great. We love that because now we've got the higher rate, we're paying the higher wage now quarter-by-quarter, we're looking at our cohort of patients and think of that cohort being between 100 patients and maybe 500 patients for specific payer. And if we don't beat the HPR percentage in that cohort, we don't get paid. .
Pito Chickering
analystShifting to home health a little bit here. It's been a challenging sector in the last 5 years, several pulp companies have grown proof -- how do you see the M&A market today? What do you look for? How good are the assets? Where are the multiples? And almost more importantly, what do you see the competition throughout the country now that these large public company acquirers, how much white space has been created?
Jeffrey Shaner
executiveI'd say to a lot. But first of all, we're robust on home health. And the way, we'd love hospice too. We're just not buyers at 13x, 15x, so in that base -- space, excuse me. But we love home health and hospice. We've been doing, as you know, for almost 30 years. The space looks different. It is -- I'm telling Matt, you've been doing this for 27 years, 1 day, you're young and the next that you wake up and you realize when everybody go. And most of them retired or had moved on. But you look around in the large players, the Amedisys is the LHCG, the Gentiva, the inhabits the Encompasses, the companies we all knew in the space are effectively all gone somewhere, most of them to payers, right, and -- or private. So I do think it's created this opportunity for the next step, the next groups that are building up the regional home health and hospice providers as well as building national networks, and we want to be one of those. We want to be the next, whether it's Gentiva or Mediscan be 1 of the next semi-national and eventually national home health and hospice providers, we're about 70, 3/4 home health, 1/4 hospice in our home of the hospice segment. So $300 million were we're 3, 4 home health. So we'll be more of a home health acquirer. And Matt loves on our team. We just got an amazing team, we've known this team for almost 3 decades. They're growing organically 15.5% year-over-year, 53%, 54% gross margin, 4.5 stars on the final TPS scores can keep going value-based CBS score windows. -- an episodic mission. It's just as a win-win for us. We need to give them more geography. They are hungry for more. They have fixed everything we've given and they've owned everything we've given them. We need to give them more both in a tuck-in format, a small regional platform and eventually something larger in nature.
Pito Chickering
analystIf I think about your preferred payer deals in home health, historically, home health has been known as area where a provider is really optimized is it in order to optimize revenues and EBITDA? Do you guys show up with all sudden different models here. I mean how much does this structurally shift entire market as payers look for a segment that historically was will say politely highly optimized.
Matt Buckhalter
executiveYes. And we think managing utilization is not the way to go, like trying to manage some of these care like provide the right amount of care in the perfect amount of care. And we have 50 preferred payers in that division, and that's up from 45 beginning this year. And we've really seen that flip One of those was Medicare. And the other 49 are MA payers out there. And we've been able to flip those MI payers from pay-per-visit models to episodic models because they're getting the savings at the end of the day here, Pito. And we talked about the great financial results we're seeing out there. But the reason we're getting it is the clinical results and the savings at the end of the day, our star rating, our TPS scores are going up. We're getting rate increases from TPS scores every single year. that's where we're seeing it. And people are realizing paying $3,000 over a 60-day period to prevent a hospitalization is really, really worth it. And it says on the administrative side as well. I mean our caregivers and our back office isn't having to run down another authorization after they did 4 PT visits when they mean to do 16 and a combination of visits that are going there as well. And so we're seeing -- it all kind of relates down to an access to care issue. And payers trying to get to that lowest cost settings that I talked about previously. But we're not seeing that slow down at all. At 81% episodic commissions. It could be a little hot. We would tell you that a really good company does a great company to 75 and us at 81 that could be a little bit hot out there. If it solely kind of trailed back down, but we still grew at 15%, 16% organically. We'd be more than happy with that as well.
Jeffrey Shaner
executiveBut I agree, Matt. This is the model. This is the model. We're not benefit. Our peers are coming around. We're not the only 1 doing this model at this point about 80% episodic. And the payers are getting more and more comfortable with adjudicating claims on an episodic arrangement. They tried for 10, 15 years to beat down the paper is fee for service and just drive on utilization I don't think it worked. I think at the end of day, it just created this huge fight between providers and payers. We just said no so many times that people eventually needed us back in their network, and they signed. But I think we can grow this. I think we can grow this we would like significant more geography over time. But I think I think these trends can continue in home health and hospice.
Pito Chickering
analystQuestion here is SG&A margin leverage again something come back to this 1 again. You're sort of guiding long-term margins 14%, 15%, be getting the last bunch of years, 100 plus 100 basis points of SG&A leverage, you're talking earlier about using AI for billing, like all these create potential leverage. I'm not talking about margins within the 3 segments. But simply as you guys keep us going here, why has not be reporting basis point margins mentioned annually?
Matt Buckhalter
executiveI think there's a combination there. Right now, if you actually look at our LRPs for gross margin, we're on the higher end of every single 1 of those. In home ownspice, we guide to 52-ish percent Medical Solutions were 42% to 44%. We're sitting at 44% and PDS for, and we're sitting at 29%. So we're doing that because there's a little bit of wage pass-through that's still planned. It's still driving our volumes. It's still driving our volume north of that 6% because of that. And so I think as that kind of matures and comes down a little bit, it just settles and normalizes out plus some of those AR benefits you talked about, Pito, are beneficial to my gross margin as well, onetime in nature. We'll still continue to leverage in terms of nature at okay. We will continue to leverage that SG&A as size, scale, density, automation continue to play out. Our team does a really good job of looking for it every single day. So is that just kind of settles a little bit, we'll see the expansion or the reduction in SG&A still and kind of end up at that same 14 and change number, and we feel really comfortable being a services company right there. .
Jeffrey Shaner
executiveAnd Matt the more we get into home health and hospice where you have to be comfortable with the PIC, the UPIC ZPIC, that's just a part of that business that in Medicaid, it's very infrequent that you're getting audits at that pace in home health and hospice, you're getting those every day. So there is a cost of that, that you've got to factor in. But I think to your point, being a Medicaid-driven company, we're still 80% plus Medicaid being a Medicaid-driven company at roughly north of 14% EBITDA feels very, very good to us comfortable. You know we don't try to gain the gross margin our payers want to know that this is going to the going to the caregivers. So we focus on driving gross margin almost down. It sounds crazy, but it's really passing the wage of the carryover and then being as efficient as we possibly can. -- could we hit 15% EBITDA, of course. I mean, I'm sure it's going to happen. But I think we -- we used to guide to into we're comfortably at 14% now. I think you'll see us between high 13s and kind of mid- to high 4s for the foreseeable future.
Pito Chickering
analystYes. I mean the 1 thing is the credit you guys have been very transparent about is as these rates come through somebody saying like it's coming down, it's coming down, it's coming down and just help drive and then the crush numbers again. So it's a different conversation. All right. We're running at time here some of these a couple of questions. Balance sheet. Again, we balance sheet is that before it was terrible and now it's great. Lots of things to fix that and EBITDA doubling somehow does a good job on a leverage ratio as just generating cash. What's the like -- what is the right leverage ratio to be running this business at in the long term? And at some point, I know that there's M&A, I know other things are going, but you're EBITDA is big, and you keep on growing with these deals. At some point, do you draw line in sand and say, "Hey, this is the right level, be X and Y. But at X, we'll never go below X because we'll just do share repo." And that gives you enough scale that you need to buy the bigger deals, having a 1 turn range in there, you buy a lot of deals for that. In the pro forma, you can buy a lot of big ones without breaking that advantage.
Matt Buckhalter
executiveI mean really proud obviously from what we've been able to do on the leverage profile. I mean we're Jeff and I took our positions, it was double digits at that point in time. And so we've done a lot of work in there. been going up. Yes. Taking cost out and taking costs out of all 3 of our divisions. And even on corporate, that drove our EBITDA up as well, the efficiencies we put in the preferred payer model, all the things that we listed here earlier. -- we've done a nice job getting it down to right around 4x, just sub-4x leverage, and there's still work to do though. Again, we know there's work to do. We have a really nice line of sight to get that to a sub-3x, and that's our goal. We want to be a sub-3x leverage company. We think that's the right balance to be out there long term itself. I think Family First is a great example of like don't be foolish though and don't have your blinders on just for anything at any given time. We closed Family First in Q2. We had 1 month of results in our financials itself. We spent roundup with fees, $180 million of cash on hand from free cash flow and cash generated, often be able to do so. And we went up 0.2 turns on that leverage. So that means we still grew EBITDA organically. We still produced $75 million free cash flow. So we did everything else to be able to go get that deal done, create density in 4 states that we really want to create density, kind of put a bow on those states at the same time. So I think it's just the thoughtfulness of being conscious about your leverage and having a goal to get to sub-3x but don't put your blinders on too much that inhibits your growth, whether it be an organic growth driver or an inorganic growth driver?
Pito Chickering
analystSo 275, that's a point where it goes below that on the Colonsay to start buying .
Jeffrey Shaner
executiveGo do something certainly 2.5, 2.5. But I agree, Matt. Our -- we've had a clear goal of be sub-3 for now for 2 years. and we're on that march. We can see it in mid- to lay '27, exactly what Matt said, I agree with. We will absolutely do a deal slightly lever to delever right afterwards. And our answer would be, let's do both. At the end of the day, let's keep growing, let's keep driving the company north of double digits year-over-year growth and be able to deliver at the same time. .
Pito Chickering
analystPerfect. That's it. We're out of time. Guy. Thank you so much, and thank you as for ringing.
Jeffrey Shaner
executiveThanks so much. Appreciate that.
Read the full transcript via the API
You're viewing the first half of this call. Get the complete Aveanna Healthcare Holdings Inc. transcript — plus 255,000+ transcripts from 12,000+ companies, speaker segments, AI summaries and full-text search — through the EarningsCalls.dev API.
Get the API View API docs →For developers and AI pipelines
Programmatic access to Aveanna Healthcare Holdings Inc. earnings transcripts and 255,000+ others is available through the
EarningsCalls.dev REST API. Plans from $24.99/month — full transcripts, speaker segments,
full-text search, and the recently-added /api/v1/transcripts/recent polling endpoint for ETL pipelines.